In 2023, about 64,050 people will be diagnosed with pancreatic cancer and about 50,550 will die of the disease, according to the American Cancer Society. Pancreatic cancer accounts for only about 3% ...

New research by University of Colorado Cancer Center member Marco Del Chiaro, MD, PhD, one of the world’s foremost researchers on pancreatic cancer, finds that even in patients whose pancreatic cancer ...

People who are overweight or obese are at higher risk for at least 13 different types of cancer, which together make up about 40 percent of all cancer diagnoses in the United States, according to the ...

Prior to becoming the Democratic vice-presidential candidate, Kamala Harris expressed her strong support for better health care for all Americans. She credits much of her passion on this issue to her ...

A cancer diagnosis of any kind was linked to a nearly 40 percent increase in risk for shingles compared with the risk of someone without cancer. What’s more, people who had a blood-related cancer ...

Anxiety about scans, bloodwork and similar tests is a common experience for many people living with and beyond cancer, but they are finding creative ways to ease its grip.

A compound found in veggies such as broccoli, kale and Brussels sprouts may help prevent a liver condition that increases cancer risk.

Datroway, from AstraZeneca and Daiichi Sankyo, is a novel antibody-drug conjugate. It consists of an antibody that targets TROP-2 and delivers a topoisomerase inhibitor chemotherapy payload directly ...

Padcev, first approved for bladder cancer in 2019, is an antibody-drug conjugate, a monoclonal antibody targeting nectin-4 (a protein found on most urothelial cancer cells) that carries a potent ...

When given as a first-line treatment, Libtayo (cemiplimab) significantly extended overall survival and progression-free survival compared with platinum chemotherapy in people with advanced ...

The Pan-Mass Challenge (PMC), the world’s single most successful athletic fundraiser, has announced a $78 million gift for cancer research, treatment and patient care at the top-ranked Dana-Farber ...

SCLC accounts for about 12% of all lung cancer cases in the United States, and the disease is fairly aggressive, with a 9% five-year relative survival rate according to the latest data. “Most patients ...